Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Autoimmune Encephalitis
100%
Encephalitis
89%
Neurohospitalist
30%
Immune Checkpoint Inhibitors
24%
Cerebrospinal Fluid
23%
18F-fluorocholine PET/CT
18%
Anti-NMDA Receptor Encephalitis
18%
Autoimmune
18%
Etiology
18%
Seizure
18%
Neurology
16%
New-onset Refractory Status Epilepticus (NORSE)
16%
Positron Emission Tomography/computed Tomography (PET/CT)
15%
Neuroscience
14%
Super-refractory Status Epilepticus
13%
Immune-related Adverse Events (IrAEs)
13%
18F-FDG PET-CT
13%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
13%
Critical Care Unit
13%
Intensive Care Unit
12%
N-methyl-D-aspartate Receptor (NMDAR)
12%
Multiple Sclerosis
12%
Encephalomyelitis
12%
Risk Score
12%
Practice Perspective
12%
Immune Checkpoint Therapy
12%
New Onset
12%
Neurological Impairment
11%
Modified Rankin Scale
11%
Brain FDG-PET
11%
Clinical Outcomes
10%
Status Epilepticus
9%
Cerebrospinal Fluid Pleocytosis
9%
Paraneoplastic Syndrome
9%
Neurological Examination
9%
Metabolism
9%
Adult Patients
8%
Hypometabolism
8%
Methylprednisolone
8%
Acute Encephalitis
8%
Hypermetabolism
8%
Neurological Diseases
8%
Immunosuppressive Therapy
8%
FDG PET-CT
8%
HIV RNA
8%
Diagnosis Management
8%
Infectious Encephalitis
8%
Hypermetabolic
8%
Occipital Lobe
8%
Survivors
7%
Medicine and Dentistry
Encephalitis
79%
Allergic Encephalitis
64%
Status Epilepticus
38%
Intensive Care Unit
27%
Anti N Methyl D Aspartate Receptor Encephalitis
27%
Fluorodeoxyglucose
26%
Epileptic Seizure
25%
Positron Emission Tomography-Computed Tomography
25%
Neurologic Disease
23%
Magnetic Resonance Imaging
21%
Immune Checkpoint Inhibitor
21%
Etiology
19%
Cerebrospinal Fluid
19%
Burnout
18%
Electroencephalography
17%
Autoimmunity
16%
Ketogenic Diet
14%
Multiple Sclerosis
14%
Prevalence
13%
Brain Disease
13%
Neurology
11%
Occipital Lobe
11%
Retrospective Study
11%
Malignant Neoplasm
11%
Receptor
10%
Dextro Aspartic Acid
10%
Diseases
10%
Metastatic Carcinoma
10%
Autoantibodies
9%
Positron Emission Tomography
9%
NMDA Receptor
9%
Immunosuppressive Treatment
8%
Delirium
8%
Nervous System
7%
Cerebrovascular Disease
7%
Retrospective Cohort Study
7%
Hypermetabolism
7%
Fluorodeoxyglucose F 18
7%
Paraneoplastic Cerebellar Degeneration
7%
Differential Diagnosis
7%
Odds Ratio
7%
Brain Metabolism
6%
Polyethylene Terephthalate
6%
Clinician
6%
Infectious Encephalitis
6%
Vascular Neurology
6%
Connective Tissue Disease
6%
Glasgow Outcome Scale
6%
Adaptive Behavior
6%
Wernicke Korsakoff Syndrome
6%